Gossamer Bio Seeks $230M IPO Amid Government Shutdown
Biotechnology firm Gossamer Bio Inc. on Wednesday disclosed pricing details for a $230 million initial public offering, using an unconventional route that allows companies to go public without the usual green...To view the full article, register now.
Already a subscriber? Click here to view full article